Navigation Links
Zyomyx Point-of-Care CD4 Test Selected by CD4 Initiative to Help Treat HIV/AIDS Patients in Developing Countries
Date:11/17/2009

HAYWARD, Calif., Nov. 17 /PRNewswire/ -- Zyomyx, Inc., a leader in chip-based bioanalysis technologies, today announced that its readerless CD4 point-of-care (POC) technology was selected by Imperial College London's CD4 Initiative as the best-performing POC test method for measuring CD4 T-cell count in HIV/AIDS patients. Zyomyx's CD4 assay is now the only remaining POC product being supported by the CD4 Initiative. With this announcement, Zyomyx is currently entering the commercial phase of this project and is actively soliciting partnerships with global sales and distribution providers.

Zyomyx has developed the world's first, fully quantitative CD4 readout in a POC format. As simple to read as a thermometer, Zyomyx's patent-pending assay uses CD4-binding reagents to pull CD4 cells from a blood sample and transfer them to a volumetric region of the device, where cell count can be determined by a simple visual readout. The quantitative CD4 count provides critical information in the clinical management of HIV. The test will give doctors and patients in resource-poor settings with limited infrastructure the same high-quality data that is available in the rest of the world.

The CD4 Initiative was established in 2005 by an initial award of $8.6 million from the Bill & Melinda Gates Foundation and is conducted under the aegis of the Imperial College London, UK. The Initiative's objective is to develop a low-cost, instrument-free test for measuring CD4 T-cells in HIV/AIDS patients. Throughout this year, the Initiative evaluated the three remaining systems using clinical samples. Prototypes were assessed against the predicate method of flow cytometry. Results from the verification trial showed that only Zyomyx's
'/>"/>

SOURCE Zyomyx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. mPay Gateway Teams With Allscripts to Provide Point-of-Care Patient Payment Tools to Physician Practices Nationwide
2. Varian Medical Systems Selected to Supply Major Project to Bring Advanced Radiotherapy Treatments to North of Portugal
3. Sanovia Selected to Deliver PA-Logic(TM) Pharmaceutical Prior Authorization Platform to HealthSpring
4. A Unique Endoluminal Approach for the Treatment of Morbid Obesity Selected for Presentation at the 2009 American College of Surgeons Clinical Congress
5. Fresenius Medical Care, N.A. Has Selected VitalRemedyMDs VitalProteinRx(TM) As Its Bar of Choice for Protein Replacement in Dialysis Patients
6. Sangamo BioSciences Announces Research Collaboration With UCLA in Human Stem Cells Selected to Receive Clinical Research Award
7. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
8. Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research
9. Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
10. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
11. XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... y LONDRES, August 30, 2015 ... visión holística de l cuidado al ... trayecto   Royal Philips  ... debut europeo de IntelliSpace Cardiovascular , un sistema ... sofisticadas herramientas para acceder, analizar y compartir imágenes cardiovasculares ...
(Date:8/28/2015)... 2015  CytomX Therapeutics, Inc., a biopharmaceutical company developing ... the filing of a registration statement on Form S-1 ... to a proposed initial public offering of its common ... the price range for the offering have not yet ... under the symbol "CTMX" on the NASDAQ Global Market. ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... ) has announced the addition of the ... Capacity and Production" report to their offering. ... Survey of Biopharmaceutical Manufacturing Capacity and Production is ... contract manufacturing organizations, current and projected future capacity ...
Breaking Medicine Technology:Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3CytomX Files Registration Statement for Proposed Initial Public Offering 212th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 2
... 23, 2012 Idenix Pharmaceuticals, Inc. (NASDAQ: ... and development of drugs for the treatment of human ... fourth quarter and year ended December 31, 2011 as ... (HCV) development pipeline. Operational HighlightsIDX184 ...
... Psychemedics Corporation (NASDAQ: PMD ) today announced ... December 31, 2011.  The Company also announced an increase in ... of record as of March 5, 2012 to be paid ... consecutive quarterly dividend. The Company,s revenue for the ...
Cached Medicine Technology:Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 2Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 3Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 4Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 5Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 6Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 7Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 8Psychemedics Corporation Announces a 20% Increase in Revenue and a 34% Increase in Profits for 2011 Year End 2Psychemedics Corporation Announces a 20% Increase in Revenue and a 34% Increase in Profits for 2011 Year End 3Psychemedics Corporation Announces a 20% Increase in Revenue and a 34% Increase in Profits for 2011 Year End 4Psychemedics Corporation Announces a 20% Increase in Revenue and a 34% Increase in Profits for 2011 Year End 5
(Date:8/31/2015)... ... August 31, 2015 , ... Now through October 31st, the ... be featured on a digital screen projected above New York’s Times Square, on ... promote earlier awareness of the symptoms of ovarian cancer, and earlier conversations with ...
(Date:8/31/2015)... ... ... All birth control methods work best if used correctly every time you have ... Moreover, no-scalpel vasectomy has many proven advantages with a lower complication rate over the ... are afraid of complications. , One Stop Medical Center reported a zero failure ...
(Date:8/31/2015)... ... ... TheHardwareCity.com is pleased to announce the availability of the technologically-advanced and easy ... are manufactured by Allied Tools. The set consists of a selection of basic tools ... and house work to be completed easily and efficiently without the sacrifice of power ...
(Date:8/30/2015)... ... August 31, 2015 , ... Although middle market companies ... issues that are critically important to them are often overlooked when government sets ... proposed legislation and changing tax and regulatory policies. Smaller companies, which often suffer ...
(Date:8/30/2015)... IL (PRWEB) , ... August 30, 2015 , ... ... is pleased to announce that Partner Daniel M. Kotin was recently elected ... this exclusive organization constitutes the highest degree of peer recognition and outstanding professionalism. ...
Breaking Medicine News(10 mins):Health News:National Ovarian Cancer Coalition Rolls Out "TAKE ACTION. NOT CHANCES. (SM)" Campaign for September, National Ovarian Cancer Awareness Month 2Health News:National Ovarian Cancer Coalition Rolls Out "TAKE ACTION. NOT CHANCES. (SM)" Campaign for September, National Ovarian Cancer Awareness Month 3Health News:One Stop Medical Center of Twin Cities Achieves Zero Failure Rate and Infection Rate in No Scalpel Vasectomy 2Health News:TheHardwareCity.com Now Offering Allied 49032 25 Piece Tri-Fold Tool Set 2Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 2Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 3Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 4Health News:Chicago Personal Injury Lawyer Daniel M. Kotin Elected to the American Board of Trial Advocates 2Health News:Chicago Personal Injury Lawyer Daniel M. Kotin Elected to the American Board of Trial Advocates 3
... in the treatment of intestinal disorders for close to ... to be extended to people with rectal cancer. In ... or "hand-assisted" laparoscopic surgery for rectal cancer, a team ... Medical Center has shown that the minimally invasive approach ...
... Nov. 10 Reportlinker.com announces that a ... its catalogue. , Central Nervous ... , http://www.reportlinker.com/p0161866/Central-Nervous-System-Insomnia-or-Sleep-Disorders.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire , ... or Sleep Disorders contains detailed information on ...
... at Kickoff Event , HARRISBURG, Pa., Nov. 10 ... in Pennsylvania by urging students to build a rewarding ... , "There will be rising demand for many ... seven years," said Governor Rendell. "During Health Careers Week, ...
... Texas Health Presbyterian Hospital Dallas is the first hospital in ... be named a Cycle III Chest Pain Center by the ... heart attack treatment. , "This honor means that Texas Health ... rapid recognition and collaborative treatment of heart attacks," said cardiologist ...
... Mayo Clinic research studied the association between prostate-specific antigen (PSA) ... of prostate growth is not necessarily a predictor for the ... a man,s PSA level is rising quickly, a prostate biopsy ... findings are being presented this week at the ...
... Medical School estimates 2,266 U.S. military veterans under the age of ... had reduced access to care. That figure is more than 14 ... Afghanistan in 2008, and more than twice as many as have ... 2001. The researchers, who released their analysis today, pointedly say ...
Cached Medicine News:Health News:Minimally invasive surgery shown safe and effective treatment for rectal cancer 2Health News:Minimally invasive surgery shown safe and effective treatment for rectal cancer 3Health News:Reportlinker Adds Central Nervous System Insomnia or Sleep Disorders 2Health News:Reportlinker Adds Central Nervous System Insomnia or Sleep Disorders 3Health News:PA Governor Rendell Puts Focus of Health Careers Week on In-Demand Occupations 2Health News:PA Governor Rendell Puts Focus of Health Careers Week on In-Demand Occupations 3Health News:Texas Health Dallas Receives Prestigious Chest Pain Accreditation 2Health News:Routine Evaluation of Prostate Size Not as Effective in Cancer Screening, Mayo Study Finds 2Health News:Routine Evaluation of Prostate Size Not as Effective in Cancer Screening, Mayo Study Finds 3Health News:Over 2,200 veterans died in 2008 due to lack of health insurance 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: